3 results
Approved WMORecruiting
To test the hypothesis that LY3314814, administered orally at doses of 20 and 50 mg daily for 78 weeks, will slow the decline of AD ascompared with placebo in patients with mild AD dementia.
Approved WMOCompleted
(1) To compare adenoma miss rates (AMR) between Endocuff Vision-assisted colonoscopy (EAC) and conventionalcolonoscopy (CC)(2) To compare adenoma detection rates (ADR) between EAC and CC(3) To assess whether a proposed increased ADR and reduced AMR…
Approved WMORecruiting
The objective of this study is to validate the VBMEG algorithm by comparing hd-EEG with fMRI activity. If validated, it will be validated that the accuracy of the VBMEG algorithm is improved when fMRI is incorporated to the source reconstruction,…